Shree Ram Proteins Sells Land for ₹30 Crore in Related Party Transaction
Shree Ram Proteins Limited approved the sale of land for up to ₹30 crore to Sova Agrotech Private Limited. The EGM on March 5, 2026, approved the transaction, which is a related party deal. Completion is expected by April 2026.
The sale of a significant asset for ₹30 crore can have a material impact on the company's financial structure and operational focus. It also involves a related party transaction, which requires careful scrutiny.
The transaction is a related party sale of assets. While it aims to streamline operations, the related party nature warrants a neutral sentiment as it doesn't immediately indicate a significant positive or negative financial impact.
Shree Ram Proteins Limited (SRPL) has announced the approval for the sale of its land situated at Survey No. 54 P3, B/h Pan Agri Export Off. Rajkot Gondal National Highway At. Bhunava, Ta. Gondal, Dist. Rajkot - 360311. The sale, which is to Sova Agrotech Private Limited, is for a consideration not exceeding ₹30 crore (Rupees Thirty Crore only) and is to be completed in one or more tranches.
This decision was considered and approved at the company's Extra Ordinary General Meeting (EGM) held on Thursday, March 05, 2026, at 3:30 p.m. IST. The sale of the undertaking is in accordance with Regulation 37A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and section 180(1)(a) of the Companies Act, 2013, requiring shareholder approval.
The transaction has been identified as a Related Party Transaction. Ms. Geetaben Lalitbhai Vasoya, a Promoter of SRPL, is also a Director in Sova Agrotech Private Limited. Despite this, the transaction is stated to be conducted on an arm's length basis, with a fair consideration determined through independent valuation to align with prevailing market conditions. The sale is expected to be completed by April 2026. This move is intended to help the company streamline its asset base, reduce holding costs, and focus on core business operations.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.